Tekla Life Sciences Investors

NYSE: HQL · Financial Services · Asset Management

PublicHQ Philadelphia, MACIK 0000884121Reports USD

#1 of 1,011 Financial Services companies by revenue

EA Score

——

FH —DQ —GM —SS 83

v0.1 · 5/100 weight · pillars only

↑ listing tenure, market scale · ↓ Piotroski F, market scale

Methodology →

Revenue TTM

$79.8M

Rev growth YoY (TTM)

+44.5%

Net income (FY)

—

Employees

—

Market cap

$611.8M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Tekla Life Sciences Investors has no structured financials on file — private or non-XBRL filer.

Peers · Financial Services

Ridgepost Capital, Inc.54D ACNB Corporation56C River City Bank60C Northfield Bancorp, Inc.49D

Key facts

CEODaniel R. Omstead

SectorFinancial Services

IndustryAsset Management

HeadquartersPhiladelphia, MA

ExchangeNYSE: HQL

Employees—

IPO date1992-05-01

Latest filings

DEF 14A2024-04-22 8-K2023-09-12 DEF 14A2023-04-11 DEF 14A2022-04-12 DEF 14A2019-04-15 DEF 14A2018-04-18 DEF 14A2017-04-18 DEF 14A2014-04-30

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.